‘‘(I) require as appropriate that pro-
posals include milestones and goals for the 
research; 
‘‘(II) require that the proposals in-
clude timeframes for funding of the re-
search; and 
‘‘(III) ensure appropriate consider-
ation of proposals for which the principal 
investigator is an individual who has not 
previously served as the principal investi-
gator of research conducted or supported 
by the National Institutes of Health; 
‘‘(B) may, with respect to funds reserved under 
section 402A(c)(1) for the Common Fund, allocate 
such funds to the national research institutes and 
national centers for conducting and supporting re-
search that is identified under subparagraph (A); 
and 
‘‘(C) may assign additional functions to the Di-
vision in support of responsibilities identified in sub-
paragraph (A), as determined appropriate by the Di-
rector; 
‘‘(8) shall, in coordination with the heads of the 
national research institutes and national centers, en-
sure that such institutes and centers—
‘‘(A) preserve an emphasis on investigator-
initiated research project grants, including with 
respect to research involving collaboration be-
tween 2 or more such institutes or centers; and 
‘‘(B) when appropriate, maximize investi-
gator-initiated research project grants in their 
annual research portfolios; 
‘‘(9) shall ensure that research conducted or 
supported by the National Institutes of Health is 
subject to review in accordance with section 492 and 
that, after such review, the research is reviewed in 
accordance with section 492A(a)(2) by the appro-
priate advisory council under section 406 before the 
research proposals are approved for funding; 
‘‘(10) shall approve the establishment of all 
centers of excellence recommended by the national 
research institutes, other than centers recognized 
under section 414; 
‘‘(11) shall oversee research training for all of 
the national research institutes and National Re-
search Service Awards in accordance with section 
487; 
‘‘(12) may, from funds appropriated under sec-
tion 402A(b), reserve funds to provide for research 
on matters that have not received significant funding
relative to other matters, to respond to new issues 
and scientific emergencies, and to act on research 
opportunities of high priority; 
‘‘(13) may, subject to appropriations Acts, col-
lect and retain registration fees obtained from third 
parties to defray expenses for scientific, educational, 
and research-related conferences;’’. 
(b) CERTAIN AUTHORITIES.—Section 402 of the 
Public Health Service Act (42 U.S.C. 282) is amended—
(1) by striking subsections (i) and (l); and 
(2) by redesignating subsections (j) and (k) as 
subsections (i) and (j), respectively. 
(c) ADVISORY COUNCIL FOR DIRECTOR OF NIH.—
Section 402 of the Public Health Service Act, as amended 
by subsection (b) of this section, is amended by adding 
after subsection (j) the following subsection: 
‘‘(k) COUNCIL OF COUNCILS.—
‘‘(1) ESTABLISHMENT.—The Director of NIH 
shall establish within the Office of the Director an 
advisory council to be known as the ‘Council of 
Councils’ (referred to in this subsection as the 
‘Council’) for the purpose of advising the Director 
on matters related to the policies and activities of 
the Division of Program Coordination, Planning, 
and Strategic Initiatives, including making rec-
ommendations with respect to the conduct and sup-
port of research described in subsection (b)(7). 
‘‘(2) MEMBERSHIP.—
‘‘(A) IN GENERAL.—The Council shall be 
composed of 27 members selected by the Direc-
tor of NIH with approval from the Secretary 
from among the list of nominees under sub-
paragraph (C). 
‘‘(B) CERTAIN REQUIREMENTS.—In select-
ing the members of the Council, the Director of 
NIH shall ensure—
‘‘(i) the representation of a broad 
range of disciplines and perspectives; and 
‘‘(ii) the ongoing inclusion of at least 
1 representative from each national re-
search institute whose budget is substan-
tial relative to a majority of the other in-
stitutes. 
‘‘(C) NOMINATION.—The Director of NIH 
shall maintain an updated list of individuals 
who have been nominated to serve on the Coun-
cil, which list shall consist of the following: 
‘‘(i) For each national research insti-
tute and national center, 3 individuals 
nominated by the head of such institute or
center from among the members of the ad-
visory council of the institute or center, of 
which—
‘‘(I) two shall be scientists; and 
‘‘(II) one shall be from the gen-
eral public or shall be a leader in the 
field of public policy, law, health pol-
icy, economics, or management. 
‘‘(ii) For each office within the Divi-
sion of Program Coordination, Planning, 
and Strategic Initiatives, 1 individual nom-
inated by the head of such office. 
‘‘(3) TERMS.—
‘‘(A) IN GENERAL.—The term of service 
for a member of the Council shall be 6 years, 
except as provided in subparagraphs (B) and 
(C). 
‘‘(B) TERMS OF INITIAL APPOINTEES.—Of 
the initial members selected for the Council, the 
Director of NIH shall designate—
‘‘(i) nine for a term of 6 years; 
‘‘(ii) nine for a term of 4 years; and 
‘‘(iii) nine for a term of 2 years. 
‘‘(C) VACANCIES.—Any member appointed 
to fill a vacancy occurring before the expiration
of the term for which the member’s predecessor 
was appointed shall be appointed only for the 
remainder of that term. A member may serve 
after the expiration of that member’s term until 
a successor has taken office.’’. 
(d) REVIEW BY ADVISORY COUNCILS OF RESEARCH 
PROPOSALS.—Section 492A(a)(2) of the Public Health 
Service Act (42 U.S.C. 289a–1(a)(2)) is amended by in-
serting before the period the following: ‘‘, and unless a 
majority of the voting members of the appropriate advi-
sory council under section 406, or as applicable, of the 
advisory council under section 402(k), has recommended 
the proposal for approval’’. 
(e) CONFORMING AMENDMENT.—Section 402(a) of 
the Public Health Service Act (42 U.S.C. 282(a)) is 
amended by striking ‘‘Director of the National Institutes 
of Health’’ and all that follows through ‘‘who shall’’ and 
inserting ‘‘Director of NIH who shall’’. 
(f) RULE OF CONSTRUCTION REGARDING AUTHORI-
TIES
OF NATIONAL RESEARCH INSTITUTES
AND NA-
TIONAL CENTERS.—This Act and the amendments made 
by this Act may not be construed as affecting the authori-
ties of the national research institutes and national centers 
that were in effect under the Public Health Service Act 
on the day before the date of the enactment of this Act,
subject to the authorities of the Director of NIH under 
section 401 of the Public Health Service Act (as amended 
by section 2(a) of this Act). For purposes of the preceding 
sentence, the terms ‘‘national research institute’’, ‘‘na-
tional center’’, and ‘‘Director of NIH’’ have the meanings 
given such terms in such section 401. 
SEC. 4. AUTHORIZATION OF APPROPRIATIONS. 
(a) FUNDING.—Title IV of the Public Health Service 
Act (42 U.S.C. 281 et seq.) is amended by inserting after 
section 402 the following: 
‘‘SEC. 402A. AUTHORIZATION OF APPROPRIATIONS. 
‘‘(a) IN GENERAL.—For the purpose of carrying out 
this title, there are authorized to be appropriated—
‘‘(1) $29,747,874,000 for fiscal year 2007; 
‘‘(2) $31,235,268,000 for fiscal year 2008; and 
‘‘(3) $32,797,032,000 for fiscal year 2009. 
‘‘(b) OFFICE OF THE DIRECTOR.—Of the amount au-
thorized to be appropriated under subsection (a) for a fis-
cal year, there are authorized to be appropriated for pro-
grams and activities under this title carried out through 
the Office of the Director of NIH the following amount, 
as applicable to the fiscal year: 
‘‘(1) $1,000,000,000 for fiscal year 2007. 
‘‘(2) $1,050,000,000 for fiscal year 2008. 
‘‘(3) $1,102,500,000 for fiscal year 2009.
‘‘(c) TRANS-NIH RESEARCH.—
‘‘(1) COMMON FUND.—
‘‘(A) 
ANNUAL
RESERVATION
OF 
AMOUNTS.—Of the total amount appropriated 
under subsection (a) for fiscal year 2007 or any 
subsequent fiscal year, the Director of NIH 
shall reserve the applicable amount under sub-
paragraph (B) for allocations under section 
402(b)(7)(B) (relating to research identified by 
the Division of Program Coordination, Plan-
ning, and Strategic Initiatives), which reserva-
tions shall constitute an account to be known as 
the Common Fund. 
‘‘(B) AMOUNT OF RESERVATION.—Subject 
to subparagraph (C), the amount reserved by 
the Director of NIH under subparagraph (A) 
for a fiscal year shall be the sum of—
‘‘(i) the base amount determined 
under subparagraph (D); and 
‘‘(ii) any additional amount deter-
mined under subparagraph (E). 
Amounts reserved under the preceding sentence 
shall remain available until expended. 
‘‘(C) MAXIMUM RESERVATION.—
‘‘(i) IN
GENERAL.—The amount re-
served by the Director of NIH under sub-
paragraph (A) for a fiscal year shall not 
exceed 5 percent of the total amount ap-
propriated under subsection (a) for such 
fiscal year, subject to clause (ii). 
‘‘(ii) APPLICABILITY.—Clause (i) may 
not apply with respect to any fiscal year 
beginning after the submission of rec-
ommendations under subparagraph (F). 
‘‘(iii) PRESERVATION
OF
RESERVA-
TION.—For any fiscal year following the 
first fiscal year for which the percentage 
that applies for purposes of clause (i) is 5 
percent, the reservation under subpara-
graph (A) for the fiscal year involved may 
not be less than 5 percent of the total 
amount appropriated under subsection (a) 
for such fiscal year. For fiscal year 2008 
and each subsequent fiscal year, the per-
centage constituted by the reservation 
under subparagraph (A) relative to the 
total amount appropriated under sub-
section (a) for the fiscal year involved may 
not be less than the percentage constituted
by the reservation under such subpara-
graph for the preceding fiscal year relative 
to the total amount appropriated under 
subsection (a) for such preceding fiscal 
year. 
‘‘(D) BASE
AMOUNT.—The base amount 
referred to in subparagraph (B)(i) for a fiscal 
year is—
‘‘(i) for fiscal year 2007, the amount 
reserved by the Director of NIH for fiscal 
year 2006 for research described in section 
402(b)(7)(A)(i); and 
‘‘(ii) for fiscal year 2008 and each 
subsequent fiscal year, the amount re-
served under subparagraph (A) for the 
preceding fiscal year. 
‘‘(E) 
ADDITIONAL
AMOUNT
COR-
RESPONDING
TO
INCREASES
IN
APPROPRIA-
TIONS.—The additional amount referred to in 
subparagraph (B)(ii) is 50 percent of the 
amount by which the total amount appropriated 
under subsection (a) for the fiscal year involved 
exceeds the total amount appropriated under 
such subsection for the preceding fiscal year, 
except that for any fiscal year beginning after
the submission of recommendations under sub-
paragraph (F), such percentage may be ad-
justed by the Director of NIH, and such per-
centage shall be adjusted by the Director to the 
extent necessary for compliance with subpara-
graph (C)(iii). 
‘‘(F) EVALUATION.—During the 6-month 
period following the end of the first fiscal year 
for which the amount reserved by the Director 
of NIH under subparagraph (A) is equal to 5 
percent of the total amount appropriated under 
subsection (a) for such fiscal year, the Sec-
retary, acting through the Director of NIH, in 
consultation with the advisory council estab-
lished under section 402(k), shall submit rec-
ommendations to the Congress for changes to 
the amount of the reservation under subpara-
graph (A). 
‘‘(2) TRANS-NIH RESEARCH REPORTING.—
‘‘(A) LIMITATION.—With respect to the 
total amount appropriated under subsection (a) 
for fiscal year 2008 or any subsequent fiscal 
year, if the head of a national research institute 
or national center fails to submit the report re-
quired by subparagraph (B) for the preceding
fiscal year, the amount made available for the 
institute or center for the fiscal year involved 
may not exceed the amount made available for 
the institute or center for fiscal year 2006. 
‘‘(B) REPORTING.—Not later than Janu-
ary 1, 2008, and each January 1st thereafter—
‘‘(i) the head of each national re-
search institute or national center shall 
submit to the Director of NIH a report on 
the amount made available by the institute 
or center for conducting or supporting re-
search that involves collaboration between 
the institute or center and 1 or more other 
national research institutes or national 
centers; and 
‘‘(ii) the Secretary shall submit a re-
port to the Congress identifying the per-
centage of funds made available by each 
national research institute and national 
center with respect to such fiscal year for 
conducting or supporting research de-
scribed in clause (i). 
‘‘(C) DETERMINATION.—For purposes of 
determining the amount or percentage of funds 
to be reported under subparagraph (B), any
amounts made available to an institute or cen-
ter under section 402(b)(7)(B) shall be in-
cluded. 
‘‘(D) VERIFICATION OF AMOUNTS.—Upon 
receipt of each report submitted under subpara-
graph (B)(i), the Director of NIH shall review 
and verify the accuracy of the amounts speci-
fied in the report. 
‘‘(E) WAIVER.—At the request of any na-
tional research institute or national center, the 
Director of NIH may waive the application of 
this paragraph to such institute or center if the 
Director finds that the conduct or support of 
research described in subparagraph (B)(i) is in-
consistent with the mission of such institute or 
center. 
‘‘(d) TRANSFER AUTHORITY.—Of the total amount 
appropriated under subsection (a) for a fiscal year, the 
Director of NIH may (in addition to the reservation under 
(c)(1) for such year) transfer not more than 1 percent for 
programs or activities that are authorized in this title and 
identified by the Director to receive funds pursuant to this 
subsection. In making such transfers, the Director may 
not decrease any appropriation account under subsection 
(a) by more than 1 percent.
‘‘(e) RULE OF CONSTRUCTION.—This section may 
not be construed as affecting the authorities of the Direc-
tor of NIH under section 401.’’. 
(b) ELIMINATION OF OTHER AUTHORIZATIONS OF 
APPROPRIATIONS.—Title IV of the Public Health Service 
Act (42 U.S.C. 281 et seq.) is amended—
(1) by striking the first sentence of paragraph 
(5) of section 402(i) (as redesignated by section 
3(b)); 
(2) by striking subsection (e) of section 403A; 
(3) by striking subsection (c) of section 404B; 
(4) by striking subsection (h) of section 404E; 
(5) by striking subsection (d) of section 404F; 
(6) by striking subsection (e) of section 404G; 
(7) by striking subsection (d) of section 409A; 
(8) in section 409B—
(A) in subsection (a), by striking ‘‘under 
subsection (e)’’ and inserting ‘‘to carry out this 
section’’; and 
(B) by striking subsection (e); 
(9) by striking subsection (e) of section 409C; 
(10) in section 409D—
(A) by striking subsection (d); and 
(B) by redesignating subsection (e) as sub-
section (d);
(11) by striking subsection (e) of section 409E; 
(12) by striking subsection (c) of section 409F; 
(13) in section 409H, by striking—
(A) paragraph (3) of subsection (a); 
(B) paragraph (3) of subsection (b); 
(C) paragraph (5) of subsection (c); and 
(D) paragraph (4) of subsection (d); 
(14) by striking subsection (d) of section 409I; 
(15) by striking section 417B; 
(16) by striking subsection (g) of section 417C; 
(17) in section 417D, by striking—
(A) paragraph (3) of subsection (a); and 
(B) paragraph (3) of subsection (b); 
(18) by striking subsection (d) of section 424A; 
(19) by striking subsection (c) of section 424B; 
(20) by striking section 425; 
(21) by striking subsection (d) of section 434A; 
(22) by striking subsection (d) of section 441A; 
(23) by striking subsection (c) of section 442A; 
(24) in section 445H—
(A) by striking subsection (b); and 
(B) in subsection (a), by striking ‘‘(a)’’; 
(25) by striking subsection (d) of section 445I; 
(26) by striking section 445J; 
(27) in section 447A—
(A) by striking subsection (b); and 
(B) in subsection (a), by striking ‘‘(a)’’; 
(28) by striking subsection (d) of section 447B; 
(29) by striking subsection (g) in section 452A; 
(30) by striking paragraph (7) in section 
452E(b); 
(31) in section 452G—
(A) by striking subsection (b); and 
(B) in subsection (a), by striking ‘‘(a) EN-
HANCED SUPPORT.—’’; 
(32) by striking subsection (d) of section 464H; 
(33) by striking subsection (d) of section 464L; 
(34) by striking paragraph (4) of section 
464N(c); 
(35) by striking subsection (e) of section 464P; 
(36) by striking subsection (f) of section 464R; 
(37) by striking subsection (d) of section 464z; 
(38) in section 467—
(A) by striking the first sentence; 
(B) by striking ‘‘for such buildings and fa-
cilities’’ and inserting ‘‘for suitable and ade-
quate buildings and facilities for use of the Li-
brary’’; and 
(C) by striking ‘‘The amounts authorized 
to be appropriated by this section include’’ and
inserting ‘‘Amounts appropriated to carry out 
this section may be used for’’; 
(39) by striking section 468; 
(40) in section 481A—
(A) in the matter preceding subparagraph 
(A) of subsection (c)(2)—
(i) by striking the term ‘‘under sub-
section (i)(1)’’ and inserting ‘‘to carry out 
this section’’; and 
(ii) by striking ‘‘under such sub-
section’’ and inserting ‘‘to carry out this 
section’’; and 
(B) by striking subsection (i); 
(41) in subsection (a) of section 481B, by strik-
ing ‘‘under section 481A(h)’’ and inserting ‘‘to carry 
out section 481A’’; 
(42) by striking subsection (c) in the section 
481C that relates to general clinical research cen-
ters; 
(43) by striking subsection (e) in section 485C; 
(44) by striking subsection (l) in section 485E; 
(45) by striking subsection (h) in section 485F; 
(46) by striking subsection (e) in section 485G; 
(47) by striking subsection (d) of section 487;
(48) by striking subsection (c) of section 487A; 
and 
(49) by striking subsection (c) in the section 
487F that relates to a loan repayment program re-
garding clinical researchers. 
(c) RULE OF CONSTRUCTION REGARDING CONTINU-
ATION OF PROGRAMS.—The amendment of a program by 
a provision of subsection (b) may not be construed as ter-
minating the authority of the Federal agency involved to 
carry out the program. 
SEC. 5. REPORTS. 
(a) REPORT OF DIRECTOR OF NIH.—The Public 
Health Service Act (42 U.S.C. 201 et seq.), as amended 
by section 4(a) of this Act, is amended—
(1) by redesignating section 403A as section 
403C; 
(2) in section 1710(a), by striking ‘‘section 
403A’’ and inserting ‘‘section 403C’’; and 
(3) by striking section 403 and inserting the 
following sections: 
‘‘SEC. 402B. ELECTRONIC CODING OF GRANTS AND ACTIVI-
TIES. 
‘‘The Secretary, acting through the Director of NIH, 
shall establish an electronic system to uniformly code re-
search grants and activities of the Office of the Director
and of all the national research institutes and national 
centers. The electronic system shall be searchable by a va-
riety of codes, such as the type of research grant, the re-
search entity managing the grant, and the public health 
area of interest. When permissible, the Secretary, acting 
through the Director of NIH, shall provide information 
on relevant literature and patents that are associated with 
research activities of the National Institutes of Health. 
‘‘SEC. 403. BIENNIAL REPORTS OF DIRECTOR OF NIH. 
‘‘(a) IN GENERAL.—The Director of NIH shall sub-
mit directly to the Congress on a biennial basis a report 
in accordance with this section. The first report shall be 
submitted not later than 1 year after the date of the enact-
ment of the National Institutes of Health Reform Act of 
2006. Each such report shall include the following infor-
mation: 
‘‘(1) An assessment of the state of biomedical 
and behavioral research. 
‘‘(2) A description of the activities conducted or 
supported by the agencies of the National Institutes 
of Health and policies respecting the programs of 
such agencies. 
‘‘(3) Classification and justification for the pri-
orities established by the agencies, including a stra-
tegic plan and recommendations for future research
initiatives to be carried out under section 402(b)(7) 
through the Division of Program Coordination, 
Planning, and Strategic Initiatives. 
‘‘(4) A catalog of all the research activities of 
the agencies, prepared in accordance with the fol-
lowing: 
‘‘(A) The catalog shall, for each such activ-
ity—
‘‘(i) identify the agency or agencies in-
volved; 
‘‘(ii) state whether the activity was 
carried out directly by the agencies or was 
supported by the agencies and describe to 
what extent the agency was involved; and 
‘‘(iii) identify whether the activity was 
carried out through a center of excellence. 
‘‘(B) In the case of clinical research, the 
catalog shall, as appropriate, identify study 
populations by demographic variables and other 
variables that contribute to research on health 
disparities. 
‘‘(C) Research activities listed in the cata-
log shall include the following: 
‘‘(i) Epidemiological studies and longi-
tudinal studies.
‘‘(ii) Disease registries, information 
clearinghouses, and other data systems. 
‘‘(iii) Public education and informa-
tion campaigns. 
‘‘(iv) Training activities, including 
National Research Service Awards and a 
breakdown by demographic variables and 
other appropriate categories. 
‘‘(v) Clinical trials, including a break-
down of participation by study populations 
and demographic variables and such other 
information as may be necessary to dem-
onstrate compliance with section 492B (re-
garding inclusion of women and minorities 
in clinical research). 
‘‘(vi) Translational research activities 
with other agencies of the Public Health 
Service. 
‘‘(5) A summary of the research activities 
throughout the agencies, which summary shall be or-
ganized by the following categories: 
‘‘(A) Cancer. 
‘‘(B) Neurosciences. 
‘‘(C) Life stages, human development, and 
rehabilitation.
‘‘(D) Organ systems. 
‘‘(E) Autoimmune diseases. 
‘‘(F) Genomics. 
‘‘(G) Molecular biology and basic science. 
‘‘(H) Technology development. 
‘‘(I) Chronic diseases, including pain and 
palliative care. 
‘‘(J) Infectious diseases and bioterrorism. 
‘‘(K) Health disparities. 
‘‘(L) Such additional categories as the Di-
rector determines to be appropriate. 
‘‘(b) REQUIREMENT REGARDING DISEASE-SPECIFIC 
RESEARCH ACTIVITIES.—In a report under subsection 
(a), the Director of NIH, when reporting on research ac-
tivities relating to a specific disease, disorder, or other ad-
verse health condition, shall—
‘‘(1) present information in a standardized for-
mat; 
‘‘(2) identify the actual dollar amounts obli-
gated for such activities; and 
‘‘(3) include a plan for research on the specific 
disease, disorder, or other adverse health condition, 
including a statement of objectives regarding the re-
search, the means for achieving the objectives, a
date by which the objectives are expected to be 
achieved, and justifications for revisions to the plan. 
‘‘(c) ADDITIONAL REPORTS.—In addition to reports 
required by subsections (a) and (b), the Director of NIH 
may submit to the Congress such additional reports as the 
Director determines to be appropriate. 
‘‘SEC. 403A. ANNUAL REPORTING TO INCREASE INTER-
AGENCY COLLABORATION AND COORDINA-
TION. 
‘‘(a) COLLABORATION WITH OTHER HHS AGEN-
CIES.—On an annual basis, the Director of NIH shall sub-
mit to the Secretary a report on the activities of the Na-
tional Institutes of Health involving collaboration with 
other agencies of the Department of Health and Human 
Services. 
‘‘(b) CLINICAL TRIALS.—Each calendar year, the Di-
rector of NIH shall submit to the Commissioner of Food 
and Drugs a report that identifies each clinical trial that 
is registered during such calendar year in the databank 
of information established under section 402(j). 
‘‘(c) HUMAN TISSUE SAMPLES.—On an annual basis, 
the Director of NIH shall submit to the Congress a report 
that describes how the National Institutes of Health and 
its agencies store and track human tissue samples.
‘‘(d) FIRST REPORT.—The first report under sub-
sections (a), (b), and (c) shall be submitted not later than 
1 year after the date of the enactment of the National 
Institutes of Health Reform Act of 2006. 
‘‘SEC. 403B. ANNUAL REPORTING TO PREVENT FRAUD AND 
ABUSE. 
‘‘(a) WHISTLEBLOWER COMPLAINTS.—
‘‘(1) IN GENERAL.—On an annual basis, the 
Director of NIH shall submit to the Inspector Gen-
eral of the Department of Health and Human Serv-
ices, the Secretary, the Committee on Energy and 
Commerce of the House of Representatives, and the 
Committee on Health, Education, Labor, and Pen-
sions of the Senate a report summarizing the activi-
ties of the National Institutes of Health relating to 
whistleblower complaints. 
‘‘(2) CONTENTS.—For each whistleblower com-
plaint pending during the year for which a report is 
submitted under this subsection, the report shall 
identify the following: 
‘‘(A) Each agency of the National Insti-
tutes of Health involved. 
‘‘(B) The status of the complaint. 
‘‘(C) The resolution of the complaint to 
date.
‘‘(b) EXPERTS AND CONSULTANTS.—On an annual 
basis, the Director of NIH shall submit to the Inspector 
General of the Department of Health and Human Serv-
ices, the Secretary, the Committee on Energy and Com-
merce of the House of Representatives, and the Committee 
on Health, Education, Labor, and Pensions of the Senate 
a report that—
‘‘(1) identifies the number of experts and con-
sultants, including any special consultants, whose 
services are obtained by the National Institutes of 
Health or its agencies; 
‘‘(2) specifies whether such services were ob-
tained under section 207(f), section 402(d), or other 
authority; 
‘‘(3) describes the qualifications of such experts 
and consultants; 
‘‘(4) describes the need for hiring such experts 
and consultants; and 
‘‘(5) if such experts and consultants make fi-
nancial disclosures to the National Institutes of 
Health or any of its agencies, specifies the income, 
gifts, assets, and liabilities so disclosed. 
‘‘(c) FIRST REPORT.—The first report under sub-
sections (a) and (b) shall be submitted not later than 1
year after the date of the enactment of the National Insti-
tutes of Health Reform Act of 2006.’’. 
(b) STRIKING
OF OTHER REPORTING REQUIRE-
MENTS FOR NIH.—
(1) PUBLIC HEALTH SERVICE ACT; TITLE IV.—
Title IV of the Public Health Service Act, as amend-
ed by section 4(b) of this Act, is amended—
(A) in section 404E(b)—
(i) by amending paragraph (3) to read 
as follows: 
‘‘(3) COORDINATION OF CENTERS.—The Direc-
tor of NIH shall, as appropriate, provide for the co-
ordination of information among centers under para-
graph (1) and ensure regular communication be-
tween such centers.’’; and 
(ii) by striking subsection (f) and re-
designating subsection (g) as subsection 
(f); 
(B) in section 404F(b)(1), by striking sub-
paragraphs (F) and (G); 
(C) by striking section 407; 
(D) in section 409C(b), by striking para-
graph (4) and redesignating paragraphs (5) and 
(6) as paragraphs (4) and (5), respectively;
(E) in section 409E, by striking subsection 
(d); 
(F) in section 417C, by striking subsection 
(f); 
(G) in section 424B(a)—
(i) in paragraph (1), by adding ‘‘and’’ 
after the semicolon at the end; 
(ii) in paragraph (2), by striking ‘‘; 
and’’ and inserting a period; and 
(iii) by striking paragraph (3); 
(H) in section 429, by striking subsections 
(c) and (d); 
(I) in section 442, by striking subsection 
(j) and redesignating subsection (k) as sub-
section (j); 
(J) in section 464D, by striking subsection 
(j); 
(K) in section 464E, by striking subsection 
(e); 
(L) in section 464T, by striking subsection 
(e); 
(M) in section 481A, by striking subsection 
(h); 
(N) in section 485E, by striking subsection 
(k);